Joseph Hernandez
Script error: No such module "AfC submission catcheck".
| Joseph Hernandez | |
|---|---|
| Born | |
| 🏫 Education | University of Florida (BS, MS, MBA); Yale University (MS); Oxford University (MS - in process) |
| 💼 Occupation | Businessman · Philanthropist |
Joseph Hernandez is an American entrepreneur, philanthropist, healthcare executive and biotech executive. He is the former Founder and CEO of several healthcare and pharmaceutical companies, including Innovative Biosensors, Ember Therapeutics, Noachis Terra and Blue Water Biotech. Currently, Joseph serves as Founder and Senior Managing Partner of Blue Water Venture Partners LLC.
In addition to creating biotechnology companies, Joseph has several years experience serving on various company corporate Board of Directors.
Education[edit]
In a 2017 short bio for the Association of Hispanic Alumni, Hernandez is quoted as saying that he "attributes much of his success to the mentorship received at UF".[1]
Career[edit]
Early career[edit]
Joseph Hernandez began his career in December 1998 when he was hired at Merck & Co. His experience at the pharmaceutical giant has been described as the "foundational development to his biotech and pharmaceutical career".[2]
In 2005, Hernandez went back east and began working for Digene Corp, a molecular diagnostics company focusing on the area of Human Papillomavirus (HPV). It was here that Hernandez assisted in developing the first test for HPV, leading to the company's acquisition by Qiagen in 2007.[3]
Entrepreneurship and leadership[edit]
Hernandez then founded Microlin Bio, a development stage biotechnology company focused on developing microRNA-based therapeutics for cancer. In 2013, the company partnered with Ohio State University in a license agreement for the University's cancer portfolio of microRNA patents in researching and developing more effective ways to diagnose and treat prostate, ovarian, colon and lung cancers.[4] The company went on to be publicly traded in 2015.
In 2018, Hernandez founded Blue Water Vaccines, a company dedicated to manufacturing a universal influenza vaccine, in collaboration with the University of Oxford. In 2022, Hernandez successfully led the company to launch an IPO. Members of the corporation, along with Hernandez, rang the closing bell on February 18, 2022.[5]
While developing Blue Water Vaccines, Hernandez was also setting up another company. Founded in 2020, Noachis Terra was a biotechnology company focusing on developing a COVID-19 vaccine. Hernandez successfully navigated the company's acquisition by Oragenic just five short months after its official incorporation.[6]
Hernandez, known for his ability to work several projects simultaneously, founded Blue Water Special Acquisition Corp. in 2020. In April of 2021, Blue Water Special Acquisition Corp. merged with Claris Therapeutic Holdings Inc.[7]
Philanthropy[edit]
In 2017, Hernandez committed a donation of $10 million dollars to the University of Florida. The university noted the donation as the largest received from someone under 50 years old.[1]
Beyond his contributions to the University of Florida, Hernandez's commitment to advancing scientific knowledge extended to funding the sequencing of the dodo genome at the University of Oxford.[8] The research, which started in 2020, focused on gaining scientific insight into the genetic mechanisms in hopes of understanding the evolution of extinct island birds losing the ability to fly.
References[edit]
- ↑ 1.0 1.1 "Joe Hernandez, Gran Caiman". Association of Hispanic Alumni. 2017. Retrieved January 10, 2024.
- ↑ "Joseph Hernandez, Blue Water Vaccines: Developing Transformative Vaccines to Address Major Health". Docwire News. March 9, 2023. Retrieved January 15, 2024.
- ↑ Flaherty, Michael (August 9, 2007). "Netherlands' Qiagen buying Digene for $1.6bln". Reuters. Retrieved January 13, 2024.
- ↑ "The Ohio State University Partners with Microlin Bio Inc. to Bring the University's Transformational Cancer Discoveries to Patients". The James, The Ohio State University Comprehensive Cancer Center. October 10, 2013. Retrieved January 15, 2024.
- ↑ "Bluewater Vaccines Rings the Nasdaq Stock Market Closing Bell". Nasdaq. February 18, 2022. Retrieved January 27, 2024.
- ↑ Dagen, Sara (May 4, 2020). "Oragenics Acquires Noachis Terra Inc., to Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing "Spike Protein"". UF Innovate. Retrieved January 29, 2024.
- ↑ "Blue Water Acquisition Corporation Announces Merger Agreement with Clarus Therapeutics, Forming A Publicly Listed Company To Address Unmet Needs Of Men And Women Through Development Of Androgen And Metabolic Therapies". www.prnewswire.com. April 27, 2021. Retrieved January 29, 2024.
- ↑ "Project for whole genome sequencing of extinct flightless birds". University of Oxford. October 27, 2020. Retrieved January 22, 2024.
External links[edit]
- Developing a Lifetime, Universal Influenza Vaccine. (J.Hernandez. Interview. Conducted by John Parkinson for Contagion Live. 04 December 2020)
- Founder Joseph Hernandez Talks Blue Water Acquisition Corp. (J.Hernandez. Interview. Conducted for The Watch List. 13 January 2021)
- SPACs and infectious disease past and future, Joe Hernandez, CEO, Blue Water Acquisition Corp. (J.Hernandez. Interview. conducted for SoundCloud. 30 March 2021)
- Interview with Blue Water Chairman Joe Hernandez. (J.Hernandez. Podcast Interview. Conducted by David E. Williams for Health Business Group. 29 July 2021)
- Joseph Hernandez The Chief Executive Officer of Blue Water Vaccines Konusmasi. (J.Hernandez. Interview. Conducted for Istanbul Ekonomi Zirvesi. 03 January 2022)
- Blue Water Vaccines: Using vaccines to solve global health challenges. (J.Hernandez. Interview. Conducted by Jane King for LilaMax Media. 05 November 2022)
- Moving Vaccine Technologies from Lab to Market with Joe Hernandez Blue Water Vaccines. (J.Hernandez. Podcast Interview. Conducted by Karen Jagoda for Empowered Patient Podcast. 11 October 2022)
- Joseph Hernandez, Transforming the Biotechnology Industry. (2022 December, Joseph Hernandez, Luxury Magazine, Volume 126, Issue 2022, Pg 77. retrieved from https://issuu.com/luxurymag/docs/joseph_hernandez_-en-luxury_n126-issuu)
- The Oxford Dodo?...Joe Hernandez, Blue Water Vaccines. (J.Hernandez. Interview. Conducted by Dr. Moira Gunn for BioTech Nation. 15 February 2023)
- Joseph Hernandez, Blue Water Vaccines: Developing Transformative Vaccines to Address Major Health Challenges. (J.Hernandez, Interview. Conducted by Rob Dillard for DocWire News. 9 March 2023)
This article "Joseph Hernandez (entrepreneur)" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Joseph Hernandez (entrepreneur). Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
